journal
https://read.qxmd.com/read/38719499/effectiveness-utilisation-and-cost-associated-with-implantable-loop-recorders-versus-external-monitors-after-ischaemic-or-cryptogenic-stroke
#1
MULTICENTER STUDY
Sanket S Dhruva, Jaime Murillo, Omid Ameli, Christine E Chaisson, Rita F Redberg, Ken Cohen
OBJECTIVE: Implantable loop recorders (ILRs) are increasingly used for long-term rhythm monitoring after ischaemic and cryptogenic stroke, with the goal of detecting atrial fibrillation (AF) and subsequent initiation of oral anticoagulation to reduce risk of adverse clinical outcomes. There is a need to determine the effectiveness of different rhythm monitoring strategies in this context. METHODS: We conducted a retrospective cohort analysis of individuals with commercial and Medicare Advantage insurance in Optum Labs Data Warehouse who had incident ischaemic or cryptogenic stroke and no prior cardiovascular implantable electronic device from 1 January 2016 to 30 June 2021...
May 8, 2024: Open Heart
https://read.qxmd.com/read/38719498/effects-of-trimetazidine-on-heart-failure-with-reduced-ejection-fraction-and-associated-clinical-outcomes-a-systematic-review-and-meta-analysis
#2
JOURNAL ARTICLE
Soufiane Nassiri, Arno A Van de Bovenkamp, Sharon Remmelzwaal, Olimpia Sorea, Frances de Man, M Louis Handoko
BACKGROUND: Despite maximal treatment, heart failure (HF) remains a major clinical challenge. Besides neurohormonal overactivation, myocardial energy homoeostasis is also impaired in HF. Trimetazidine has the potential to restore myocardial energy status by inhibiting fatty acid oxidation, concomitantly enhancing glucose oxidation. Trimetazidine is an interesting adjunct treatment, for it is safe, easy to use and comes at a low cost. OBJECTIVE: We conducted a systematic review to evaluate all available clinical evidence on trimetazidine in HF...
May 8, 2024: Open Heart
https://read.qxmd.com/read/38719497/continuous-heart-monitoring-to-evaluate-treatment-effects-in-pulmonary-hypertension
#3
JOURNAL ARTICLE
Mads Ørbæk Andersen, Soren Zoga Diederichsen, Jesper Hastrup Svendsen, Jørn Carlsen
BACKGROUND: The treatment of pulmonary hypertension (PH) has improved rapidly in recent decades. There is increasing evidence to support the role of early intervention and treatment in affecting clinical outcomes in PH. OBJECTIVES: To assess treatment effects before and after the escalation of specific PH treatments using continuous heart monitoring with a Reveal LINQ loop recorder. METHODS: Patients were compared before and after treatment escalation...
May 7, 2024: Open Heart
https://read.qxmd.com/read/38702088/heterogeneity-of-right-ventricular-echocardiographic-parameters-in-systemic-lupus-erythematosus-among-four-clinical-subgroups-as-stratified-by-clinical-organ-involvement-in-observational-cohort
#4
JOURNAL ARTICLE
Corentin Bourg, Erwan Le Tallec, Elizabeth Curtis, Charlotte Lee, Guillaume Bouzille, Emmanuel Oger, Alain Lescort, Erwan Donal
BACKGROUND: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Cardiac involvement in SLE is rare but plays an important prognostic role. The degree of cardiac involvement according to SLE subsets defined by non-cardiac manifestations is unknown. The objective of this study was to identify differences in transthoracic echocardiography (TTE) parameters associated with different SLE subgroups. METHODS: One hundred eighty-one patients who fulfilled the 2019 American College of Rheumatology/EULAR classification criteria for SLE and underwent baseline TTE were included in this cross-sectional study...
May 3, 2024: Open Heart
https://read.qxmd.com/read/38688715/analysis-of-core-outcome-set-reporting-in-coronary-intervention-trials
#5
REVIEW
Aaron Duncan, Frances Shiely
BACKGROUND: This paper will focus on outcome reporting within percutaneous coronary intervention (PCI) trials. A core outcome set (COS) is a standardised set of outcomes that are recommended to be reported in every clinical trial. Using a COS can help to ensure that all relevant outcomes are consistently reported across clinical trials. In 2018, the European Society of Cardiology outlined the only COS published for PCI trials. METHODS: We searched the literature for all randomised controlled trials published between 2014 and 2022...
April 30, 2024: Open Heart
https://read.qxmd.com/read/38663890/characterisation-of-the-octogenarians-presenting-to-the-diagnostic-heart-failure-clinic-sheaf-registry
#6
MULTICENTER STUDY
Luke Thompson, Fiona Carr, Dominic Rogers, Nigel Lewis, Athanasios Charalampopoulos, Graham Fent, Pankaj Garg, Andrew J Swift, Abdallah Al-Mohammad
INTRODUCTION: Heart failure (HF) incidence is increasing in older adults with high hospitalisation and mortality rates. Treatment is complicated by side effects and comorbidities. We investigated the clinical characteristics of octogenarians presenting to the HF clinic. METHODS: Data were collected on octogenarians (80-89 years) referred to the HF clinic in two periods. The data included demographics, HF phenotype, comorbidities, symptoms and treatment. We investigate the temporal changes in clinical characteristics using χ2 test...
April 24, 2024: Open Heart
https://read.qxmd.com/read/38663889/aetiology-and-predictors-of-major-bleeding-events-in-patients-with-heart-failure-with-reduced-ejection-fraction-undergoing-percutaneous-coronary-intervention
#7
JOURNAL ARTICLE
Meghana Iyer, Rohan Shah, Weili Zheng, Khaled M Ziada, Umesh Khot, Amar Krishnaswamy, Samir R Kapadia, Grant W Reed
OBJECTIVES: We sought to determine the relationship between the degree of left ventricular ejection fraction (LVEF) impairment and the frequency and type of bleeding events after percutaneous coronary intervention (PCI). DESIGN: This was an observational retrospective cohort analysis. Patients who underwent PCI from 2009 to 2017 were identified from our institutional National Cardiovascular Disease Registry (NCDR) CathPCI database. Patients were stratified by pre-PCI LVEF: preserved (≥50%), mildly reduced (41%-49%) and reduced (≤40%) LVEF...
April 24, 2024: Open Heart
https://read.qxmd.com/read/38626934/review-of-codelists-used-to-define-hypertension-in-electronic-health-records-and-development-of-a-codelist-for-research
#8
JOURNAL ARTICLE
Georgie May Massen, Philip W Stone, Harley H Y Kwok, Gisli Jenkins, Richard J Allen, Louise V Wain, Iain Stewart, Jennifer Kathleen Quint
BACKGROUND AND AIMS: Hypertension is a leading risk factor for cardiovascular disease. Electronic health records (EHRs) are routinely collected throughout a person's care, recording all aspects of health status, including current and past conditions, prescriptions and test results. EHRs can be used for epidemiological research. However, there are nuances in the way conditions are recorded using clinical coding; it is important to understand the methods which have been applied to define exposures, covariates and outcomes to enable interpretation of study findings...
April 15, 2024: Open Heart
https://read.qxmd.com/read/38589204/new-era-in-heart-failure-management-implementing-cutting-edge-therapies-effectively
#9
EDITORIAL
Anastasia Shchendrygina, Clara Saldarriaga
No abstract text is available yet for this article.
April 8, 2024: Open Heart
https://read.qxmd.com/read/38569670/virtual-reality-to-reduce-periprocedural-anxiety-during-invasive-coronary-angiography-rationale-and-design-of-the-vr-incard-trial
#10
JOURNAL ARTICLE
Esther Helena Wouda Breunissen, Tjitske Diederike Groenveld, Linda Garms, Judith L Bonnes, Harry van Goor, Peter Damman
INTRODUCTION: Patients undergoing invasive coronary angiography (ICA) experience anxiety due to various reasons. Procedural anxiety can lead to physiological and psychological complications, compromising patient comfort and overall procedural outcomes. Benzodiazepines are commonly used to reduce periprocedural anxiety, although the effect is modest. Virtual reality (VR) is a promising non-pharmacological intervention to reduce anxiety in patients undergoing ICA. METHODS AND ANALYSIS: A single-centre open-label randomised controlled trial is conducted assessing the effectiveness of add-on VR therapy on anxiety in 100 patients undergoing ICA and experiencing anxiety in a periprocedural setting...
April 2, 2024: Open Heart
https://read.qxmd.com/read/38569669/outcomes-of-subsequent-pregnancy-in-women-with-peripartum-cardiomyopathy-a-systematic-review-and-meta-analysis
#11
JOURNAL ARTICLE
Matthew Aldo Wijayanto, Risalina Myrtha, Graciella Angelica Lukas, Annisa Aghnia Rahma, Shafira Nur Hanifa, Hadiqa Almas Zahira, Muhana Fawwazy Ilyas
INTRODUCTION: The primary concern for women who have experienced peripartum cardiomyopathy (PPCM) is the safety of a subsequent pregnancy (SSP). To maximie decision-making, facilitate effective patient counselling, and ultimately improve maternal and fetal outcomes as a whole, it is critical to comprehend the outcomes of SSP in women who have previously experienced PPCM. This study aimed to evaluate the outcomes of SSP in women with PPCM. METHODS: Three databases (PubMed, Scopus, and ScienceDirect) were used to identify relevant studies prior to 17 October 2023...
April 2, 2024: Open Heart
https://read.qxmd.com/read/38569668/arrhythmias-and-cardiac-mri-associations-in-patients-with-established-cardiac-dystrophinopathy
#12
JOURNAL ARTICLE
John Bourke, Margaret Tynan, Hannah Stevenson, Leslie Bremner, Oscar Gonzalez-Fernandez, Adam K McDiarmid
AIMS: Some patients with cardiac dystrophinopathy die suddenly. Whether such deaths are preventable by specific antiarrhythmic management or simply indicate heart failure overwhelming medical therapies is uncertain. The aim of this prospective, cohort study was to describe the occurrence and nature of cardiac arrhythmias recorded during prolonged continuous ECG rhythm surveillance in patients with established cardiac dystrophinopathy and relate them to abnormalities on cardiac MRI. METHODS AND RESULTS: A cohort of 10 patients (36...
April 2, 2024: Open Heart
https://read.qxmd.com/read/38553013/coronary-artery-disease-and-outcomes-following-transcatheter-aortic-valve-implantation
#13
JOURNAL ARTICLE
Sameer Kurmani, Bhavik Modi, Aditya Mukherjee, David Adlam, Amerjeet Banning, Andrew Ladwiniec, Raj Rajendra, Julia Baron, Elved Roberts, Andre Ng, Iain Squire, Gerald McCann, Nilesh J Samani, Jan Kovac
BACKGROUND: Aortic stenosis is a life-limiting condition for which transcatheter aortic valve implantation (TAVI) is an established therapy. Coronary artery disease (CAD) is frequently found in this patient group and optimal management in these patients remains uncertain. OBJECTIVES: We sought to examine the association of coexistent CAD on mortality and hospital readmission in patients undergoing TAVI. METHODS: In this observational cohort study, we examined patients who underwent TAVI and segregated them by the presence of obstructive epicardial CAD...
March 29, 2024: Open Heart
https://read.qxmd.com/read/38553012/oral-anticoagulation-therapy-initiation-in-patients-with-atrial-fibrillation-in-relation-to-world-region-of-origin-a-register-based-nationwide-study
#14
JOURNAL ARTICLE
Juliane Frydenlund, Jan Brink Valentin, Marie Norredam, Lars Frost, Sam Riahi, Kristian Hay Kragholm, Henrik Bøggild, Gregory Y H Lip, Søren Paaske Johnsen
BACKGROUND: Atrial fibrillation (AF) is the most common sustained arrhythmia and results in a high risk of stroke. The number of immigrants is increasing globally, but little is known about potential differences in AF care across migrant populations. AIM: To investigate if initiation of oral anticoagulation therapy (OAC) differs for patients with incident AF in relation to country of origin. METHODS: A nationwide register-based study covering 1999-2017...
March 29, 2024: Open Heart
https://read.qxmd.com/read/38538065/trends-in-transcatheter-aortic-valve-implantation-practice-and-clinical-outcomes-at-an-irish-tertiary-referral-centre
#15
JOURNAL ARTICLE
Richard Tanner, Daniele Giacoppo, Hassan Saber, David Barton, Declan Sugrue, Andrew Roy, Gavin Blake, Mark S Spence, Ronan Margey, Ivan P Casserly
OBJECTIVE: A paucity of data exists on how transcatheter aortic valve implantation (TAVI) practice has evolved in Ireland. This study sought to analyse temporal trends in patient demographics, procedural characteristics, and clinical outcomes at an Irish tertiary referral centre. METHODS: The prospective Mater TAVI database was divided into time tertiles based on when TAVI was performed: Group A, November 2008-April 2013; Group B, April 2013-September 2017; and Group C, September 2017-February 2022...
March 27, 2024: Open Heart
https://read.qxmd.com/read/38538064/prevalence-of-transthyretin-cardiac-amyloidosis-in-patients-with-high-degree-av-block
#16
JOURNAL ARTICLE
Douglas Cannie, Kush Patel, Alexandros Protonotarios, Imogen Heenan, Athanasios Bakalakos, Petros Syrris, Leon Menezes, Perry M Elliott
OBJECTIVE: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiac disorder caused by deposition of wild type or mutated transthyretin. As ATTR-CM is associated with conduction disease, we sought to determine its prevalence in patients with idiopathic high-degree atrioventricular (AV) block requiring permanent pacemaker (PPM) implantation. METHODS: Consecutive patients aged 70-85 years undergoing PPM implantation for idiopathic high-degree AV block between November 2019 and November 2021 were offered a 3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) scan...
March 27, 2024: Open Heart
https://read.qxmd.com/read/38508658/multimorbidity-in-patients-with-atrial-fibrillation
#17
REVIEW
Michelle Lobeek, Melissa E Middeldorp, Isabelle C Van Gelder, Michiel Rienstra
There is an escalating trend in both the incidence and prevalence of atrial fibrillation (AF). AF is linked to numerous other comorbidities, contributing to the emergence of multimorbidity. The sustained rise in multimorbidity and AF prevalences exerts a significant strain on healthcare systems globally. The understanding of the relation between multimorbidity and AF is essential to determine effective healthcare strategies, improve patient outcomes to adequately address the burden of AF. It not only begins with the accurate identification of comorbidities in the setting of AF...
March 19, 2024: Open Heart
https://read.qxmd.com/read/38508657/comparison-of-troponin-and-natriuretic-peptides-in-takotsubo-syndrome-and-acute-coronary-syndrome-a-meta-analysis
#18
JOURNAL ARTICLE
Liam Steven Couch, James W Garrard, John A Henry, Rafail A Kotronias, Bashir Alaour, Giovanni Luigi De Maria, Keith M Channon, Adrian P Banning, Alexander Richard Lyon, Michael Marber, Thomas Edward Kaier
OBJECTIVE: Takotsubo syndrome (TTS) is an acute heart failure syndrome which resembles acute coronary syndrome (ACS) at presentation. Differentiation requires coronary angiography, but where this does not occur immediately, cardiac biomarkers may provide additional utility. We performed a meta-analysis to compare troponin and natriuretic peptides (NPs) in TTS and ACS to determine if differences in biomarker profile can aid diagnosis. METHODS: We searched five literature databases for studies reporting NPs (Brain NP (BNP)/NT-pro-BNP) or troponin I/T in TTS and ACS, identifying 28 studies for troponin/NPs (5618 and 1145 patients, respectively)...
March 19, 2024: Open Heart
https://read.qxmd.com/read/38490715/efficacy-of-colchicine-in-addition-to-anakinra-in-patients-with-recurrent-pericarditis
#19
JOURNAL ARTICLE
Valentino Collini, Alessandro Andreis, Marzia De Biasio, Maria De Martino, Miriam Isola, Nicole Croatto, Veronica Lepre, Luca Cantarini, Marco Merlo, Gianfranco Sinagra, Antonio Abbate, George Lazaros, Antonio Brucato, Allan L Klein, Massimo Imazio
AIM: Anakinra, an anti IL-1 agent targeting IL-1 alfa and beta, is available for the treatment of recurrent pericarditis in cases with corticosteroid dependence and colchicine resistance after failure of conventional therapies. However, it is unclear if the combination with colchicine, a non-specific inhibitor of the inflammasome targeting the same inflammatory pathway of IL-1, could provide additional benefit to prevent further recurrences. The aim of the present observational study is to assess whether the addition of colchicine on top of anakinra could prolong the time to first recurrence and prevent recurrences better than anakinra alone...
March 15, 2024: Open Heart
https://read.qxmd.com/read/38485286/diagnostic-accuracy-of-baseline-troponin-and-troponin-change-for-the-diagnosis-of-myocardial-infarction-complicated-with-heart-failure
#20
JOURNAL ARTICLE
Matteo Serenelli, Beatrice Dal Passo, Simone Biscaglia, Paolo Tolomeo, Luca Di Ienno, Anna Cantone, Federico Sanguettoli, Roberta Campana, Federico Marchini, Matteo Arzenton, Daniele Maio, Valentino Santori, Gianluca Campo
BACKGROUND: The diagnosis of myocardial infarction (MI) in the presence of heart failure (HF) presents a clinical problem. While diagnostic algorithms using high-sensitivity cardiac troponin have been established for suspected MI, their accuracy in patients with HF remains uncertain. This study aims to assess the diagnostic accuracy of high-sensitivity troponin I (TnI) levels in identifying acute MI among patients with HF, focusing on baseline, absolute and relative TnI changes. METHODS: Data from 562 individuals admitted to the emergency department with suspected MI were retrospectively analysed...
March 14, 2024: Open Heart
journal
journal
49317
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.